FNOAI — SUNPHARMA

SUNPHARMA SUN PHARMACEUTICAL IND L

Overview Price & levels F&O Financials & peers Companyas of Thu 15 Oct 15:30

SUN PHARMACEUTICAL IND L — on this desk since 2 Jan 2006.

Results meeting in 14 days Fri 30 Oct 2026, as the company announced it to NSE

Prices before Thu 14 Jul 2016 are not comparable with today's. A corporate action in this security carries no published ratio, so nothing before that date can be put on the same share count — it is left out rather than shown unadjusted.

1,764.00

adjusted for splits, bonuses and dividends

Day

1.01%

Against NIFTY, month

-3.3%

its return less the index's, same sessions

Against NIFTY, quarter

-5.1%

Typical day

1.88%

its own 20-session range

Traded value

293.7 cr

20-session average

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_state · commit 4ccbd35

Where it stands

as of Thu 15 Oct 15:30

lower highs and lower lows, back inside the last decline.

Movement: mixed
Sessions measured: 279
Delivered: 65.9%

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_structure · commit 4ccbd35

Its own last sixty sessions

as of Thu 15 Oct 15:30

Traded value sat inside its own last 60 sessions.

The session’s range sat inside its own last 60.

Each is a rank against this stock's own history, not a comparison with any other stock and not a number from a distribution.

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_state · commit 4ccbd35

What changed

as of Tue 13 Oct 15:30

13 Oct 2026a rating assignedCRISIL AAA/Stable
reaffirmed.
SUNPHARMA filed a credit rating action from CRISIL.
Sources
Filed
NSE · 2026-10-13 17:54 IST
Document
raw/nse_announcement_docs/2026-10-13/15f447bafbf2_15f447bafbf2_SUNSEC_13102026175414_Intimation_to_SE_-_NCDs_Credit_Ratings.pdf · SHA-256 15f447bafbf2
Read from
“Crisil AAA/Stable (Assigned)” · page 1 · characters 1213–1241
Read by
claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed

What such filings have been followed by

as of Tue 13 Oct 15:30

a rating assigned of CRISIL AAA/Stable, reaffirmed.

Over	In	Beyond its normal day	Beyond what options priced
This stock	the next session	0 of 4	2 of 4
This stock	the next five sessions	0 of 3	1 of 3
Its industry (Healthcare)	the next session	5 of 57	25 of 57
Its industry (Healthcare)	the next five sessions	6 of 55	27 of 55
Every stock	the next session	115 of 1,007	428 of 1,006
Every stock	the next five sessions	134 of 997	457 of 964

Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.

Its filings, newest first

as of Tue 13 Oct 15:30

13 Oct 2026a rating assignedCRISIL AAA/Stable
reaffirmed.
8 Sep 2026a rating assignedMoody's Baa1
reaffirmed.
17 Aug 2026regulatory or legal action
5 Aug 2026a rating keptCRISIL AAA/Stable
reaffirmed.
31 Jul 2026results
the move was <0.5x what the options priced.
24 Jul 2026acquisition, merger or stake sale
the filing states no amount.
20 Jun 2026acquisition, merger or stake sale₹271 crore
<1% of the company's market value.
11 Jun 2026dividend
22 May 2026dividend
22 May 2026dividend
22 May 2026results
the move was <0.5x what the options priced.
7 May 2026a rating keptCRISIL AAA
reaffirmed.
27 Apr 2026acquisition, merger or stake sale
the filing states no amount.
31 Jan 2026dividend
31 Jan 2026results
the move was <0.5x what the options priced.
20 Jan 2026dividend
2 Dec 2025capacity or capital spending₹3,000 crore
<1% of the company's market value.
22 Nov 2025acquisition, merger or stake sale
the filing states no amount.
5 Nov 2025results
the move was <0.5x what the options priced.
7 Oct 2025acquisition, merger or stake sale
the filing states no amount.

Every kind of filing, across the market

What has followed each state

as of Thu 15 Oct 15:30

When it stood	After	Closed higher	Of
lower highs and lower lowsnow	3 sessions	475	922
lower highs and lower lowsnow	5 sessions	482	920
lower highs and lower lowsnow	10 sessions	485	915
lower highs and lower lowsnow	21 sessions	497	914
inside its recent range	3 sessions	316	597
inside its recent range	5 sessions	332	597
inside its recent range	10 sessions	324	597
inside its recent range	21 sessions	360	587
not enough history to say	3 sessions	25	44
not enough history to say	5 sessions	24	44
not enough history to say	10 sessions	20	44
not enough history to say	21 sessions	9	44
higher highs and higher lows	3 sessions	527	976
higher highs and higher lows	5 sessions	531	976
higher highs and higher lows	10 sessions	557	976
higher highs and higher lows	21 sessions	502	976

Counts from this stock's own record: on how many of the days it stood in that state the close that many sessions later was higher. A greyed row has fewer than 30 such days, too few to read as a tendency, and its counts are printed anyway. A day whose later session has not arrived is not counted.

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_structure · commit 4ccbd35